Correction: Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study
Authors:
Published in the journal:
PLoS ONE 14(11)
Category:
Correction
doi:
https://doi.org/10.1371/journal.pone.0224976
Notice of Republication
Incorrect versions of Figs 1–5 were published in error. The publisher apologizes for this error. This article was republished on October 24, 2019 to correct for this error. Please download this article again to view the correct version.
Zdroje
1. Dicker I, Zhang S, Ray N, Beno BR, Regueiro-Ren A, Joshi S, et al. (2019) Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study. PLoS ONE 14(10): e0224076. https://doi.org/10.1371/journal.pone.0224076 31622432
Článok vyšiel v časopise
PLOS One
2019 Číslo 11
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Úspěšná resuscitativní thorakotomie v přednemocniční neodkladné péči
- Dlouhodobá recidiva a komplikace spojené s elektivní operací břišní kýly
Najčítanejšie v tomto čísle
- A daily diary study on maladaptive daydreaming, mind wandering, and sleep disturbances: Examining within-person and between-persons relations
- A 3’ UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction
- A substitution mutation in a conserved domain of mammalian acetate-dependent acetyl CoA synthetase 2 results in destabilized protein and impaired HIF-2 signaling
- Molecular validation of clinical Pantoea isolates identified by MALDI-TOF